Tyrokin Tablet 400 mg contains Imatinib Mesylate, a targeted anticancer medication used primarily in the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other malignancies. Imatinib belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking specific enzymes that promote the growth of cancer cells, thereby slowing disease progression.
Tyrokin 400 mg is designed for oral administration, providing a convenient and effective therapy for patients requiring long-term management of specific cancers. By selectively targeting cancerous cells while sparing most normal cells, it offers a precise and modern approach to cancer treatment.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Effective Cancer Therapy: Inhibits the growth of cancer cells in CML, GIST, and other tyrosine kinase-dependent cancers.
Targeted Action: Blocks BCR-ABL tyrosine kinase and other abnormal enzymes involved in cancer progression.
Oral Convenience: Enables patients to take the medication at home under medical supervision.
Improves Prognosis: Reduces disease progression and enhances survival rates in responsive malignancies.
Imatinib Mesylate selectively inhibits tyrosine kinases, particularly BCR-ABL, c-KIT, and PDGF-R. These enzymes are responsible for uncontrolled cell proliferation in certain cancers. By blocking their activity, Tyrokin prevents cancer cell growth and promotes apoptosis (programmed cell death), reducing tumor burden and slowing disease progression.
Tyrokin Tablet 400 mg is indicated for:
Chronic Myeloid Leukemia (CML): Newly diagnosed or resistant cases
Gastrointestinal Stromal Tumors (GISTs): For unresectable, recurrent, or metastatic tumors expressing c-KIT
Other malignancies: Certain rare tumors dependent on tyrosine kinase activity, as prescribed by an oncologist
The usual dose is 400 mg once daily, taken orally with water.
Can be taken with or without food.
Swallow the tablet whole; do not crush or chew.
Dosage may be adjusted by the physician based on patient response, tolerability, and treatment guidelines.
Regular monitoring of blood counts, liver function, and kidney function is recommended during therapy.
Use under the supervision of a qualified oncologist.
Inform your doctor about any pre-existing liver, kidney, or heart conditions.
Avoid self-adjusting doses or discontinuing the medication abruptly.
Pregnant or breastfeeding women should consult a doctor before use.
Monitor for potential drug interactions with other medications, including anticoagulants and CYP3A4 substrates.
Common side effects may include:
Nausea, vomiting, or diarrhea
Fatigue or weakness
Muscle cramps or joint pain
Fluid retention or swelling
Rash or mild skin reactions
Seek immediate medical attention if severe side effects occur, such as severe liver problems, heart issues, or severe allergic reactions.
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet